Latest BOXER CAPITAL, LLC Stock Portfolio
BOXER CAPITAL, LLC Performance:
2024 Q3: 3.95%YTD: 2.82%2023: 6.96%
Performance for 2024 Q3 is 3.95%, and YTD is 2.82%, and 2023 is 6.96%.
About BOXER CAPITAL, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Boxer Capital, LLC reported an equity portfolio of $2 Billions as of 30 Sep, 2024.
The top stock holdings of Boxer Capital, LLC are RVMD, TYRA, NUVL. The fund has invested 9.5% of it's portfolio in REVOLUTION MEDICINES INC and 7.4% of portfolio in TYRA BIOSCIENCES INC.
The fund managers got completely rid off ALLOGENE THERAPEUTICS INC (ALLO), AMYLYX PHARMACEUTICALS INC (AMLX) and ABSCI CORPORATION (ABSI) stocks. They significantly reduced their stock positions in POSEIDA THERAPEUTICS (PSTX), FATE THERAPEUTICS INC (FATE) and PRELUDE THERAPEUTICS INC (PRLD). Boxer Capital, LLC opened new stock positions in INSTIL BIO INC (TIL), KYMERA THERAPEUTICS INC (KYMR) and NURIX THERAPEUTICS INC (NRIX). The fund showed a lot of confidence in some stocks as they added substantially to CULLINAN THERAPEUTICS (CGEM).
The top stock holdings of Boxer Capital, LLC are RVMD, TYRA, NUVL. The fund has invested 9.5% of it's portfolio in REVOLUTION MEDICINES INC and 7.4% of portfolio in TYRA BIOSCIENCES INC.
The fund managers got completely rid off ALLOGENE THERAPEUTICS INC (ALLO), AMYLYX PHARMACEUTICALS INC (AMLX) and ABSCI CORPORATION (ABSI) stocks. They significantly reduced their stock positions in POSEIDA THERAPEUTICS (PSTX), FATE THERAPEUTICS INC (FATE) and PRELUDE THERAPEUTICS INC (PRLD). Boxer Capital, LLC opened new stock positions in INSTIL BIO INC (TIL), KYMERA THERAPEUTICS INC (KYMR) and NURIX THERAPEUTICS INC (NRIX). The fund showed a lot of confidence in some stocks as they added substantially to CULLINAN THERAPEUTICS (CGEM).
BOXER CAPITAL, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Boxer Capital, LLC made a return of 3.95% in the last quarter. In trailing 12 months, it's portfolio return was 20.01%.
New Buys
| Ticker | $ Bought |
|---|---|
| instil bio inc | 23,932,300 |
| kymera therapeutics inc | 21,298,500 |
| nurix therapeutics inc | 12,652,100 |
| uniqure nv | 10,969,200 |
| apogee therapeutics inc | 10,514,500 |
| terns pharmaceuticals inc | 6,271,680 |
| scholar rock holding corp | 6,007,500 |
| summit therapeutics inc | 5,475,000 |
New stocks bought by BOXER CAPITAL, LLC
Additions
| Ticker | % Inc. |
|---|---|
| cullinan therapeutics | 38.00 |
Additions to existing portfolio by BOXER CAPITAL, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| poseida therapeutics | -55.31 |
| fate therapeutics inc | -39.62 |
| prelude therapeutics inc | -33.49 |
| nkarta inc | -28.14 |
| century therapeutics inc | -20.43 |
BOXER CAPITAL, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| allogene therapeutics inc | -8,970,500 |
| amylyx pharmaceuticals inc | -2,850,000 |
| absci corporation | -2,156,000 |
| dbv technologies s a | -200,250 |
| atara biotherapeutics inc | -1,411,000 |
BOXER CAPITAL, LLC got rid off the above stocks
Sector Distribution
Boxer Capital, LLC has about 93% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 93 |
| Others | 7 |
Market Cap. Distribution
Boxer Capital, LLC has about 9.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 47.2 |
| SMALL-CAP | 33.5 |
| UNALLOCATED | 7 |
| MEGA-CAP | 5.5 |
| LARGE-CAP | 4 |
| MICRO-CAP | 2.8 |
Stocks belong to which Index?
About 71.4% of the stocks held by Boxer Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 71.4 |
| Others | 28.6 |
BOXER CAPITAL, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BOXER CAPITAL, LLC
Boxer Capital, LLC has 68 stocks in it's portfolio. About 54.9% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. TYRA was the most profitable stock for Boxer Capital, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 1.00 | 696,480 | 20,483,500 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 2.36 | 1,676,730 | 48,105,500 | unchanged | 0.00 | ||
| ALLO | allogene therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMLX | amylyx pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANAB | anaptysbio inc | 2.14 | 1,300,000 | 43,550,000 | unchanged | 0.00 | ||
| APLS | apellis pharmaceuticals inc | 2.44 | 1,726,000 | 49,777,800 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 0.74 | 608,614 | 14,990,200 | unchanged | 0.00 | ||
| ATRA | atara biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 1.76 | 400,000 | 35,948,000 | unchanged | 0.00 | ||
| BCAB | bioatla inc | 0.06 | 686,347 | 1,207,970 | unchanged | 0.00 | ||
| BDTX | black diamond therapeutics i | 0.11 | 506,000 | 2,201,100 | unchanged | 0.00 | ||
| BGNE | beigene ltd | 5.51 | 500,000 | 112,255,000 | unchanged | 0.00 | ||
| CGEM | cullinan therapeutics | 0.75 | 907,895 | 15,198,200 | added | 38.00 | ||
| CYTK | cytokinetics inc | 5.44 | 2,100,000 | 110,880,000 | unchanged | 0.00 | ||
| DAWN | day one biopharmaceuticals i | 0.81 | 1,189,940 | 16,575,900 | unchanged | 0.00 | ||
| DBVT | dbv technologies s a | 0.01 | 250,000 | 175,000 | new | |||
| DBVT | dbv technologies s a | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ELYM | eliem therapeutics inc | 0.65 | 2,603,190 | 13,250,200 | unchanged | 0.00 | ||
| FATE | fate therapeutics inc | 0.85 | 4,960,910 | 17,363,200 | reduced | -39.62 | ||